Showing results (41-50 of 316) with videos related to
Sort By:
Pageof 32
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Azaindole Compounds as Phosphodiesterase 4B Inhibitors for Treating Immune-Inflammatory Diseases or DisordersZhendong Song, Steven H LiangACS Medicinal Chemistry Letters|April 16, 2025
Preparation of Substituted Heterocycles and Their Use as DNA Polymerase Theta (POLQ) InhibitorsXin Zhou, Steven H LiangACS Medicinal Chemistry Letters|March 19, 2025
Novel Pyrimidinyl Sulfonamide Derivatives as GPR17 ModulatorsTaoqian Zhao, Steven H LiangACS Medicinal Chemistry Letters|July 14, 2026
Novel Substituted Carboxamides as SSTR4 AgonistsJian Rong, Steven H LiangACS Medicinal Chemistry Letters|August 20, 2025
Preparation of Novel PARP1 Inhibitors and Their Use in Cancer TreatmentXin Zhou, Steven H LiangACS Medicinal Chemistry Letters|January 14, 2026
Novel Protein Tyrosine Phosphatase Nonreceptor Type 2 (PTPN2) Inhibitors for Cancer TreatmentXin Zhou, Steven H LiangACS Medicinal Chemistry Letters|January 14, 2026
Novel Substituted Aryl Sulfonamides and Sulfuric Diamides As Transglutaminase 2 InhibitorsJian Rong, Steven H LiangACS Medicinal Chemistry Letters|January 14, 2026
Novel 2,4,6-Trisubstituted 1,3,5-Triazines as CX3CR1 Modulators for the Treatment of Cardiovascular DisordersTaoqian Zhao, Steven H LiangACS Medicinal Chemistry Letters|July 16, 2025
Synthesis of Novel Substituted N‑Heterocycles and Their Use of Selective Poly(ADP-ribose) Polymerase 1 (PARP1) InhibitorsXin Zhou, Steven H LiangACS Medicinal Chemistry Letters|October 15, 2025
Development of Novel Compounds and Methods for Treatment of PARPs Mediated DiseaseXin Zhou, Steven H LiangPageof 32